New diabetes clinical trial: Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants

Published on: May 01, 2023 at 11:00AM
Conditions:   Type 2 Diabetes Mellitus in Obese;   Heart Failure With Preserved Ejection Fraction
Interventions:   Drug: Pioglitazone;   Drug: Placebo
Sponsor:   The University of Texas Health Science Center at San Antonio
Not yet recruiting
https://ift.tt/XJ8uiMs

Comments